Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 86.00 | 105.50 | 0.8152 | 0.3970 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 91.00 | 105.50 | 0.8626 | 0.5427 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 156.25 | 71.09 | 139.00 | 105.50 | 1.3175 | 2.2458 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 104.00 | 105.50 | 0.9858 | 0.9503 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 156.25 | 71.09 | 48.00 | 105.50 | 0.4550 | -0.4983 |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 62.00 | 105.50 | 0.5877 | -0.2136 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 156.25 | 71.09 | 93.00 | 105.50 | 0.8815 | 0.6027 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 66.00 | 105.50 | 0.6256 | -0.1223 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 156.25 | 71.09 | 108.00 | 105.50 | 1.0237 | 1.0840 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 156.25 | 71.09 | 49.00 | 105.50 | 0.4645 | -0.4798 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 156.25 | 71.09 | 121.00 | 105.50 | 1.1469 | 1.5443 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 164.00 | 105.50 | 1.5545 | 3.3396 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 97.00 | 105.50 | 0.9194 | 0.7257 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 71.09 | 97.00 | 105.50 | 0.9194 | 0.7257 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 156.25 | 71.09 | 89.00 | 105.50 | 0.8436 | 0.4837 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 151.00 | 105.50 | 1.4313 | 2.7538 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 109.00 | 105.50 | 1.0332 | 1.1180 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 156.25 | 71.09 | 45.00 | 105.50 | 0.4265 | -0.5520 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 97.00 | 105.50 | 0.9194 | 0.7257 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 106.00 | 105.50 | 1.0047 | 1.0167 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 136.00 | 105.50 | 1.2891 | 2.1238 |
| BT-20 | Lapatinib | 1 | uM | 9 | 156.25 | 71.09 | 129.00 | 105.50 | 1.2227 | 1.8470 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 96.00 | 105.50 | 0.9100 | 0.6946 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 236.00 | 260.00 | 0.9077 | 0.7602 | |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 312.50 | 153.73 | 243.00 | 260.00 | 0.9346 | 0.8293 |